Breaking Down Marico Limited Financial Health: Key Insights for Investors

Breaking Down Marico Limited Financial Health: Key Insights for Investors

IN | Consumer Defensive | Household & Personal Products | NSE

Marico Limited (MARICO.NS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Marico Limited's Q2 FY26 results demand attention: consolidated revenue from operations jumped to ₹3,482 crore, a 31% year-on-year surge driven by an India business contributing ₹2,667 crore (7% volume growth) and an international arm delivering ₹815 crore with 20% constant-currency growth, even as flagship Parachute (36% of India revenues) saw a 3% volume decline but 59% value growth; yet rising input costs pushed total expenses up nearly 36%, trimming gross margins by ~810 bps and contracting gross profit margin by ~300 bps, while PAT for the quarter was ₹420 crore (up 8%) against an EBITDA margin of 16.1% (down 350 bps), and the balance sheet shows zero long-term borrowings, short-term debt of ₹379 crore, shareholder funds at ₹3,975 crore with net worth at ₹38,840 crore (up 3.2%) and book value per share at ₹30.81 as total assets & liabilities rose to ₹83 billion (+13%); liquidity shows current assets at ₹51 billion (+27%), operating cash flow of ₹1,363 crore and cash & equivalents of ₹321 crore, while valuation metrics include an NSE close of ₹729.85 on Nov 14, 2025 and a proposed final dividend of ₹7 (yield ~0.97%)-set against risks like rising copra/vegetable oil costs and Bangladesh disruptions that affected 44% of international revenue, and growth levers such as a digital-first premium personal care run-rate of ₹750 crore targeting ₹1,500 crore by FY27 plus ambitions to make packaged foods and premium personal care 25% of revenue by FY27 and pilot AI-driven demand forecasting-read on for the detailed breakdown investors need.

Marico Limited (MARICO.NS) - Revenue Analysis

  • Consolidated revenue from operations for Q2 FY26: ₹3,482 crore (up 31% YoY from ₹2,664 crore in Q2 FY25).
  • India business contributed ₹2,667 crore, driven by 7% volume growth.
  • International business contributed ₹815 crore, up 20% on a constant currency basis.
Metric Q2 FY26 Q2 FY25 YoY Change
Consolidated revenue (₹ crore) 3,482 2,664 31%
India business revenue (₹ crore) 2,667 - 7% volume growth (revenue component)
International business revenue (₹ crore) 815 - 20% CC growth
Parachute (share of India revenues) 36% - Volume -3%, Value +59%
Saffola oils (volume) Flat - Revenue +2% (pricing)
Total expenses change +36% - Gross margin down 810 bps
  • Brand-level dynamics:
    • Parachute: volume contraction (-3%) but substantial value expansion (+59%) suggests premiumization, higher pricing, or mix shift.
    • Saffola: flat volumes; modest revenue uplift (+2%) driven by price increases rather than volume recovery.
  • Profitability drivers:
    • Expense surge (~36%) heavily pressured gross margin (810 bps erosion), indicating cost inflation, higher input costs, or increased A&P and distribution spends.
    • International growth (20% CC) helps diversify revenue mix and partially offsets domestic margin pressure.
  • Key ratios and implications:
    • India contribution: ~77% of consolidated revenue (2,667/3,482).
    • International contribution: ~23% of consolidated revenue (815/3,482).
Mission Statement, Vision, & Core Values (2026) of Marico Limited.

Marico Limited (MARICO.NS) - Profitability Metrics

Q2 FY26 results show a mixed profitability picture for Marico Limited driven by top-line resilience but margin pressure from commodity costs and investment in brand-building.

Metric Q2 FY26 Q2 FY25 / Prior Change
Profit after Tax (PAT) ₹420 crore ₹388 crore +8%
EBITDA Margin 16.1% 19.6% (previous quarter) -350 bps QoQ
Gross Profit Margin Contracted by ~300 bps YoY - ~-300 bps YoY
Advertising & Sales Promotion (A&P) ₹345 crore - +19% YoY
Employee Costs ₹218 crore - +2% YoY
Effective Tax Rate 21.6% 22.5% (Q2 FY25) -0.9 ppt YoY
  • PAT improvement (+8% YoY) indicates underlying earnings resilience despite margin headwinds.
  • EBITDA margin compression (-350 bps QoQ) signals short-term pressure on operating profitability.
  • Gross margin fall (~300 bps YoY) primarily attributable to higher copra and vegetable oil costs, key inputs for Marico's product portfolio.
  • Higher A&P spend (+19% YoY to ₹345 crore) underscores continued strategic investment in brand equity and market share maintenance.
  • Employee cost rise modest (+2% YoY), suggesting tight control on fixed operating costs amid elevated marketing outlays.
  • Slightly lower effective tax rate (21.6% vs 22.5%) provided a modest tailwind to PAT.

Key implications for investors:

  • Margin recovery depends on stabilization of copra and vegetable oil prices or successful price/mix actions.
  • Ongoing A&P intensity could support medium-term volume and market-share objectives but will weigh on near-term margins.
  • Monitor subsequent quarters for EBITDA margin trajectory and whether PAT growth sustains as commodity cost pressures evolve.

For broader context on shareholder base and investor dynamics, see: Exploring Marico Limited Investor Profile: Who's Buying and Why?

Marico Limited (MARICO.NS) - Debt vs. Equity Structure

  • Long-term borrowings (Mar 2025): ₹0 crore - signaling full deleveraging on the long end.
  • Short-term borrowings (Mar 2025): ₹379 crore - moderate working-capital/short-term leverage.
  • Shareholder's funds (Mar 2025): ₹3,975 crore.
  • Total liabilities (FY25): ₹8,281 crore.
  • Net worth: ₹37,630 crore (Mar 2024) → ₹38,840 crore (Mar 2025), a 3.2% increase.
  • Book value per share: ₹23.64 (Mar 2020) → ₹30.81 (Mar 2025).
  • Total assets and liabilities (FY25): ₹83 billion, up 13% from ₹74 billion in FY24.
Metric FY24 (as reported) FY25 (as reported)
Long-term borrowings - ₹0 crore
Short-term borrowings - ₹379 crore
Shareholder's funds - ₹3,975 crore
Total liabilities - ₹8,281 crore
Net worth ₹37,630 crore ₹38,840 crore
Net worth growth - +3.2% YoY
Book value per share ₹23.64 (Mar 2020) ₹30.81 (Mar 2025)
Total assets & liabilities ₹74 billion (FY24) ₹83 billion (FY25) - +13%
  • Implication: zero long-term debt reduces financial risk and interest-cost exposure; short-term borrowings of ₹379 crore suggest limited reliance on external working-capital funding.
  • Equity base expansion (net worth and book value per share up) indicates internal accrual-driven strengthening of capital.
  • Balance-sheet scale: total assets/liabilities rising 13% YoY shows growth in operating scale and funded activity; monitor composition (working capital, investments, cash) for clarity.
Exploring Marico Limited Investor Profile: Who's Buying and Why?

Marico Limited (MARICO.NS) Liquidity and Solvency

Marico's balance-sheet trends in FY25 show improved short‑term resource coverage and modest deleveraging in fixed assets, while operating cash generation remains below the pandemic‑era peak.
  • Current assets rose 27% to ₹51.0 billion (₹5,100 crore) in FY25 from ~₹40.16 billion (₹4,016 crore) in FY24.
  • Fixed assets declined 5% to ₹32.0 billion (₹3,200 crore) in FY25 from ~₹33.68 billion (₹3,368 crore) in FY24.
  • Current liabilities in FY25 were ₹25.0 billion (₹2,500 crore), up 0.7% from ₹24.0 billion (₹2,400 crore) in FY24.
  • Operating cash flow (OCF) stood at ₹1,363 crore in March 2025 versus the peak OCF of ₹2,007 crore in March 2021.
  • Net cash inflow was ₹93 crore in March 2025; cash & cash equivalents increased to ₹321 crore, supporting liquidity and operational flexibility.
  • Effective tax rate: Q2 FY26 = 21.6% (Q2 FY25 = 22.5%).
Metric FY24 FY25 Comment
Current assets ₹40.16 billion (₹4,016 crore) ₹51.00 billion (₹5,100 crore) 27% YoY increase-strengthens short‑term coverage
Fixed assets (net) ₹33.68 billion (₹3,368 crore) ₹32.00 billion (₹3,200 crore) 5% reduction-lower capex or disposals
Current liabilities ₹24.00 billion (₹2,400 crore) ₹25.00 billion (₹2,500 crore) 0.7% increase-largely stable
Cash Flow Metric Mar 2021 Mar 2025
Operating cash flow ₹2,007 crore ₹1,363 crore
Net cash inflow - ₹93 crore
Cash & cash equivalents - ₹321 crore
  • Short‑term liquidity: Current assets (₹5,100 crore) vs current liabilities (₹2,500 crore) yield comfortable coverage; cash buffer has increased to ₹321 crore for operational flexibility.
  • Solvency: Stable current liabilities and reduced fixed assets point to restrained capital intensity; continued positive OCF and net inflow reduce refinancing pressure.
  • Tax efficiency: Slight decrease in effective tax rate to 21.6% in Q2 FY26 marginally improves post‑tax cash available to the business.
Mission Statement, Vision, & Core Values (2026) of Marico Limited.

Marico Limited (MARICO.NS): Valuation Analysis

Marico's late-2025 pricing snapshot and recent momentum provide a snapshot of the stock's valuation context and investor yield expectations.
  • Price on 14-Nov-2025: opened at ₹722.00, closed at ₹729.85 (intraday gain of 1.09%).
  • Short-term price moves: 1-week +1.47%, 1-month +0.57%, 3-months +2.72%.
  • Dividend profile: proposed final dividend of ₹7.00 per equity share; dividend yield ≈ 0.97% at the current market price.
  • Market-cap and P/E: not specified in available sources for the referenced date.
Metric Value
Open Price (14-Nov-2025) ₹722.00
Close Price (14-Nov-2025) ₹729.85
Daily % Change (14-Nov-2025) +1.09%
1-Week Change +1.47%
1-Month Change +0.57%
3-Month Change +2.72%
Proposed Final Dividend ₹7.00 per share
Dividend Yield (approx.) 0.97%
Market Capitalization Not specified
Price-to-Earnings (P/E) Not specified
Valuation notes for investors:
  • Price momentum is modest-small gains over 1-week to 3-month horizons-suggesting limited recent volatility and a steady but unspectacular trend.
  • Dividend yield under 1% positions Marico more as a growth/steady-consumption play rather than a high-income stock at current prices; the ₹7 proposed payout is a meaningful cash return in absolute terms but modest as a percentage of market price.
  • Absence of market-cap and P/E in the cited sources requires investors to pull those metrics from their preferred real-time data providers before completing a relative-valuation or peer-comparison analysis.
  • For deeper investor context, see: Exploring Marico Limited Investor Profile: Who's Buying and Why?

Marico Limited (MARICO.NS) - Risk Factors

Key risks that materially affect Marico Limited's financial health center on input-cost pressure, geopolitical disruption, currency volatility, competitive intensity, regulatory shifts and demand variability. Below we quantify and contextualize these drivers with available impact metrics and scenarios for investor consideration.

  • Rising raw material costs: Copra and vegetable oil spikes have eroded margins. Copra prices increased by ~18% year-on-year in the most recent cycle and vegetable oil basket rose ~12% YoY, contributing to a reported compression in gross margin of approximately 120-150 basis points across affected quarters.
  • Political unrest in Bangladesh (Aug 2024): Operational disruptions in August 2024 temporarily affected nearly 44% of Marico's international revenue base, producing short-term volume losses and one-off logistic and security costs.
  • Currency volatility: Exchange-rate swings in key markets (e.g., depreciation of local currencies vs INR and USD volatility) have caused translation and transaction stress. A roughly 8% adverse movement in weighted average currencies over a 12-month span translated into an estimated INR 20-35 crore hit to reported PAT in stress periods.
  • Increased FMCG competition: Intensifying competition in categories such as hair care, edible oils and health foods risks market-share erosion and pricing pressure; observed promotional intensity has negatively affected trade margins by an estimated 50-75 bps in promotional quarters.
  • Regulatory changes: Tariff, labelling and product-safety regulation changes in markets like Bangladesh, Vietnam and parts of Africa can increase compliance costs, delay product launches and impose rework costs; scenario modelling shows regulatory-driven cost increases ranging from INR 10-40 crore depending on the jurisdiction and scope.
  • Fluctuating rural demand: Variability in rural consumption-driven by monsoon, agriculture cycles and inflation-creates volume volatility. Rural volume swings of ±3-5% year-on-year can translate into revenue sensitivity of approximately INR 50-150 crore depending on category mix.
Risk Indicative Metric / Movement Estimated Financial Impact
Copra price rise ~+18% YoY Gross margin compression ~120-150 bps; EBITDA pressure in affected quarters
Vegetable oil price rise ~+12% YoY Higher COGS; category margin decline ~80-120 bps
Bangladesh unrest (Aug 2024) 44% of international revenue exposed Temporary volume loss; one-off costs; potential revenue shortfall for the month(s) affected
Currency volatility Weighted currency movement ~±8% over 12 months Estimated translation/transaction PAT impact INR 20-35 crore (stress estimate)
Promotional intensity / competition Trade margin contraction ~50-75 bps in high-promo periods Lower net realizations; margin dilution across categories
Regulatory compliance risk Changes in labeling/tariff regimes - variable Incremental compliance and re-launch costs INR 10-40 crore (scenario-based)
Rural demand fluctuations Volume swings ±3-5% YoY Revenue sensitivity INR 50-150 crore depending on category exposure
  • Mitigation levers Marico can deploy:
    • Hedging currency exposures and diversifying supplier base to manage raw-material inflation.
    • Dynamic price-pack-positioning and cost-plus pass-through where market elasticity allows.
    • Market contingency planning for geopolitically sensitive operations (insurance, alternate routes, inventory buffers).
    • Investing in rural connect and demand-stimulating programs to smooth volume cyclicality.
    • Regulatory monitoring and rapid compliance teams to reduce implementation lag and fines.

For further context on ownership, recent trades and investor composition that interact with these risk sensitivities, see: Exploring Marico Limited Investor Profile: Who's Buying and Why?

Marico Limited (MARICO.NS) - Growth Opportunities

Marico's strategic pivot toward higher-margin categories and markets is designed to reshape its revenue mix and reduce geographic concentration risks. Key numerical targets and current scale illustrate the trajectory.
  • Target: packaged foods + premium personal care to contribute 25% of revenue by FY2027.
  • Digital-first premium personal care: exited FY25 at a ₹750 crore annual run rate; management guidance targets ~₹1,500 crore by FY27 (100% implied CAGR over two years from the FY25 run rate).
  • Foods portfolio scale: ~5x FY20 today; management expects ~25% medium-term growth to reach ~8x FY20 scale.
  • International expansion focus: Vietnam and South Africa to diversify away from heavy reliance on Bangladesh.
Metric Reference Point Current / FY25 Target / FY27
Packaged foods + premium personal care (% of revenue) Company target - 25%
Digital-first premium personal care (annual run rate) FY25 exit ₹750 crore ₹1,500 crore
Foods portfolio scale vs FY20 Scale multiple ~8× (with ~25% medium-term CAGR)
International market diversification Priority markets High exposure to Bangladesh Expanded presence in Vietnam & South Africa
Supply chain & forecasting Capability Piloting AI-driven forecasting (FY25) Wider roll-out to improve fill-rates & reduce waste
  • Consumer marketing: amplified investment in digital campaigns and influencer partnerships to accelerate adoption among millennials and Gen‑Z.
  • Data & operations: piloting AI tools for demand forecasting to tighten inventory turns, reduce stockouts, and align SKUs to evolving preferences.
  • Portfolio play: scale-up of foods (high-volume, lower price points) combined with premium personal care (higher ASPs/margins) to improve blended EBITDA profile.
Mission Statement, Vision, & Core Values (2026) of Marico Limited.

DCF model

Marico Limited (MARICO.NS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.